← TrialMatch
HomeTrials

Migraine Attack Pain Phase Prediction Study

The study of the ability to predict pain in a migraine attack, through premonitory symptoms and through an ambulatory monitoring device through real-time recording of hemodynamic variables, is one of the strategic lines of research of the unit. of Headaches at the Hospital de La Princesa since 2013 together with the Co

Condition(s)Migraine, Migraine Headache, Migraine Disorders, Migraine Without Aura, Migraine With Aura
StatusRecruiting
Study typeObservational
SummaryThe study of the ability to predict pain in a migraine attack, through premonitory symptoms and through an ambulatory monitoring device through real-time recording of hemodynamic variables, is one of the strategic lines of research of the unit. of Headaches at the Hospital de La Princesa since 2013 together with the Complutense and Polytechnic University of Madrid. Their results have been reflected in various publications (Pagán J, et al. Sensors 2015; Gago-Veiga AB, et al. J Pain Res 2018) and have promoted the creation of several invention patents.
Who can participateInclusion Criteria: * Age between 15 years and 69 years. * Diagnosed with migraine by a headache neurologist and according to the criteria proposed by ICHD-3. * History of migraine of at least 1 year of evolution. * Normal neurological examination. * Have given your informed consent. * Be able to describe your clinical situation and the characteristics of your headache. * Have an average of 10 to 14 migraine days per month in the three months prior to inclusion (high-frequency episodic migraine). * User-level management capacity of "smartphone" type electronic devices. * Be able to complete two months of study follow-up. Exclusion Criteria: * Presence of another type of headache, with the exception of headache due to excessive use of analgesic medication. * Cognitive deficiency or any othe
Ages18 Years to 65 Years
SexAll
Accepts healthy volunteersYes
Lead sponsorFundación de Investigación Biomédica - Hospital Universitario de La Princesa
LocationsMadrid, Spain
Start date2023-10-09
NCT IDNCT06459635
Official listinghttps://clinicaltrials.gov/study/NCT06459635

🔍 Search all trials →